In a landmark move within the life sciences sector, Novo Holdings has announced its acquisition of Catalent, Inc. in an all-cash transaction valued at $16....
Biopharma M&A in 2023 Biopharma M&A activity has witnessed a decisive rebound in 2023, with aggregate deal value up by 79% vs. 2022 to reach ~$152...
As we stand on the precipice of 2024, the life sciences industry continues its dynamic evolution, propelled by groundbreaking discoveries, technological ad...
71% intracranial objective response rate (iORR) in BriaCell patients with Central Nervous System (CNS) metastases support clinical efficacy of Bria-IMT&t...
More than 90% of pancreatic cancer cases are attributed to an aggressive, deadly form of the disease called pancreatic ductal adenocarcinoma, or PDAC. Rese...
The paper presents final analysis results from a multicenter, double-blind, phase 3, randomized controlled study (NCT05582629) evaluating the efficacy and ...
More than three in five (63%) people in the UK experience barriers to health inclusion People in UK, Canada and France face the longest waiting times to...
The assembly of the chromosomes, and a set of related biological insights, are among the findings published online November 8 in 10 papers in the journals ...
– Risk of death was reduced by 53% in patients treated with enfortumab vedotin plus pembrolizumab compared to chemotherapy – – Enfo...
Historical Perspective Traditionally, the Middle East's economy has been heavily reliant on its vast reserves of oil and natural gas. However, the region'...
Progress on Environment, Social and Governance (ESG) goals reflected in QIAGEN securing a „Prime“ rating and among the industry leaders with IS...
In the world of biotechnology and pharmaceuticals, innovation is the lifeblood of progress. And in the picturesque Basel area, this spirit of innovation is...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines...
The first part of the influential CPHI Annual Report predicts sizeable progress ahead for AI’s use in pharma, as despite the wider excitement around ...
© 2025 Biopharma Boardroom. All Rights Reserved.
